How FDA Drug Review Contributed to the Opioid Epidemic
Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.
Reforming Regulation to Promote Medical Use of Psychedelic Drugs
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.
Keeping Fraudulent Shrimp Out of Your Cocktail
The U.S. government is clamping down on seafood fraud and illegal fishing for shrimp imports.
The Medical Marijuana Delusion
Regulation of marijuana has been based on a false distinction for almost a century.
“Right to Try” Marks New Era in the Treatment of Terminally Ill Patients
The Right to Try Act represents an important step toward helping dying patients with little recourse.
Groups of a Feather Regulate Together
A flock of regulators and industry representatives have a seat at the turkey-regulating table.
Proposed Rule Aims to Make Drug Pricing More Transparent
A proposed requirement to display drug list prices in advertisements draws controversy.
How State and Federal Food Regulations Can—and Should—Work Together
Experts argue that gaps in federal food safety rules require state governments to step up.
Regulatory Collaboration Is Key to Public Health Success
Federal health agencies should work together to address public health problems.
Invoking a Right to Try in Regenerative Medicine
Scholars caution against using the Right to Try Act to skirt regulation for regenerative therapies.
FDA Reform Needs to Look More Like Tax Reform
U.S. regulators should model the medical device classification process on recent tax reform.
Responding to Anti-Regulatory Tropes
Marchand’s argument questions key regulatory processes and ignores the net benefits of regulation.